GlassScriptPhysician profile
Corey Michael Goolsby
NPI 1790120681
$11,590.23
in general payments reported to CMS, 2019-2025
17 companies · $7,754 in 2025
The $7,754 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,475 · 2020: $14.33 · 2021: $239 · 2022: $302 · 2023: $314 · 2024: $493 · 2025: $7,754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,675 · Travel and Lodging: $2,223 · Food and Beverage: $1,651 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,675.00 |
| Travel and Lodging | $2,222.60 |
| Food and Beverage | $1,650.93 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $8,075.12 | 2022-2025 | |
| Wright Medical Technology, INC. | $2,301.82 | 2019 | |
| Stryker Corporation | $298.90 | 2019-2025 | Augment Injectable |
| Bone Support INC. | $203.86 | 2025 | Cerament G, Ceramentbone Void Filler |
| Angiodynamics, INC. | $149.24 | 2023 | Auryon Laser System 100-120 Vac |
| Sanara Medtech INC. | $133.75 | 2021 | |
| Nevro Corp. | $96.17 | 2022-2024 | Senza |
| Smith+Nephew, INC. | $72.17 | 2019-2025 | Regranex, Collagenase Santyl |
| Baudax Bio INC. | $66.17 | 2021 | |
| Paratek Pharmaceuticals, INC. | $38.45 | 2022-2023 | Nuzyra |
| Abbvie INC. | $35.62 | 2022-2023 | |
| Bioventus LLC | $25.71 | 2019 | |
| Integra Lifesciences Corporation | $24.38 | 2021 | |
| Kerecis Limited | $21.53 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.12 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrosurface Incorporated | $14.33 | 2020 | |
| Horizon Therapeutics Plc | $13.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Goolsby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.